ꯁꯦꯕꯤꯅ ꯑꯥꯏ. ꯚꯤ. ꯖꯤ. ꯇ ꯭ ꯔꯁ ꯭ ꯇꯇ ꯑꯦꯁ. ꯑꯦ. ꯑꯦꯁ. ꯇꯤ. ꯅꯤꯌꯝ 3,4, ꯑꯃꯁꯨꯡ 5ꯗꯒꯤ ꯑꯔꯦꯞꯄ ꯄꯤ ꯫
ꯑꯣꯔꯗꯔ ꯑꯁꯤꯅ ꯑꯥꯏ. ꯚꯤ. ꯖꯤ. ꯇ ꯭ ꯔꯁ ꯭ ꯇꯇ ꯋꯥꯗꯤꯂꯥꯜ ꯑꯦꯟꯇꯔꯄ ꯭ ꯔꯥꯏꯖ ꯭ ꯁ ꯂꯤꯃꯤꯇꯦꯗꯗ ꯁꯦꯌꯔꯁꯤꯡ ꯂꯧꯊꯣꯛꯄ ꯑꯃꯁꯨꯡ ꯚꯣꯠ ꯊꯥꯗꯕꯒꯤ ꯍꯛꯁꯤꯡ ꯂꯧꯊꯣꯛꯄꯒꯤ ꯋꯥꯐꯝ ꯊꯝꯈꯤꯕꯒꯤꯗꯃꯛ ꯑꯀꯛꯅꯕ ꯂꯧꯁꯤꯟꯕꯒꯤ ꯆꯠꯅ ꯀꯥꯡꯂꯣꯟꯁꯤꯡꯗꯒꯤ (ꯑꯦꯁ. ꯑꯦ. ꯑꯦꯁ. ꯇꯤ. ꯅꯤꯌꯝꯁꯤꯡ, 2011ꯒꯤ ꯅꯤꯌꯝ 3,4, ꯑꯃꯁꯨꯡ 5) ꯑꯔꯦꯞꯄ ꯑꯃ ꯄꯤ ꯫ ꯂꯧꯁꯤꯟꯕꯒꯤ ꯊꯕꯛ ꯑꯁꯤ ꯃꯊꯪ-ꯃꯅꯥꯎ ꯅꯥꯏꯅ ꯇꯧꯅꯕ ꯄ ꯭ ꯔꯣꯃꯣꯇꯔ ꯏꯃꯨꯡꯒꯤ ꯃꯅꯨꯡꯗ ꯃꯅꯨꯡꯗ ꯑꯃꯨꯛ ꯍꯟꯅ ꯁꯦꯝꯖꯤꯟ-ꯁꯥꯖꯤꯟ ꯇꯧꯕ ꯑꯃ ꯑꯣꯏꯅ ꯐꯣꯡꯗꯣꯛꯈꯤ ꯫
ꯋꯥꯗꯤꯂꯥꯜ ꯑꯦꯟꯇꯔꯄ ꯭ ꯔꯥꯏꯖ ꯭ ꯁ ꯂꯤꯃꯤꯇꯦꯗ (ꯇꯔꯀꯦꯠ ꯀꯝꯄꯅꯤ), ꯑꯥꯏ. ꯚꯤ. ꯖꯤ. ꯇ ꯭ ꯔꯁ ꯭ ꯠ (ꯑꯦꯀ ꯭ ꯋꯤꯌꯔꯔ ꯇ ꯭ ꯔꯁ ꯭ ꯠ), ꯕꯤꯔꯦꯟꯗ ꯭ ꯔꯚꯥꯏ ꯔꯥꯝꯆꯟꯗ ꯭ ꯔ ꯒꯥꯟꯙꯤ (ꯇ ꯭ ꯔꯥꯟꯁꯐꯔꯔ), ꯑꯦꯛꯁꯤꯂ ꯭ ꯔꯣꯗ ꯄ ꯭ ꯔꯥꯏꯚꯦꯠ ꯂꯤꯃꯤꯇꯦꯗ, ꯑꯃꯁꯨꯡ ꯒꯥꯟꯙꯤ ꯄ ꯭ ꯔꯣꯃꯣꯇꯔ ꯏꯃꯨꯡꯒꯤ ꯇꯣꯉꯥꯟ-ꯇꯣꯉꯥꯟꯕ ꯃꯤꯍꯨꯠꯁꯤꯡ (ꯏꯂꯥ ꯚꯤ ꯒꯥꯟꯙꯤ, ꯖꯟꯃꯥꯖꯌ ꯕꯤꯔꯦꯟꯗ ꯭ ꯔꯚꯥꯏ ꯒꯥꯟꯙꯤ, ꯑꯃꯁꯨꯡ ꯁꯦꯌꯔꯍꯣꯜꯗꯤꯡ ꯇꯦꯕꯜꯁꯤꯡꯗ ꯂꯤꯁꯠ ꯇꯧꯔꯕ ꯑꯇꯣꯞꯄꯁꯤꯡ ꯌꯥꯎꯅ) ꯫
- ꯁꯦꯕꯤꯅ ꯑꯦꯁ. ꯑꯦ. ꯑꯦꯁ. ꯇꯤ. ꯔꯦꯒꯨꯂꯦꯁꯟ, 2011ꯒꯤ ꯔꯦꯒꯨꯂꯦꯁꯟ 3,4, ꯑꯃꯁꯨꯡ 5ꯗꯒꯤ ꯑꯔꯦꯞꯄ ꯑꯃ ꯄꯤꯈꯤ ꯫
- تجویز ꯇꯧꯔꯕ ꯇ ꯭ ꯔꯥꯟꯖꯦꯛꯁꯟ ꯑꯁꯤꯗ ꯋꯥꯗꯤꯂꯥꯜ ꯑꯦꯟꯇꯔꯄ ꯭ ꯔꯥꯏꯖ ꯭ ꯁ ꯂꯤꯃꯤꯇꯦꯗꯀꯤ ꯁꯦꯌꯔꯁꯤꯡꯒꯤ 10.64% ꯑꯗꯨ ꯍꯛꯊꯦꯡꯅꯅ ꯂꯧꯁꯤꯟꯕ ꯑꯃꯁꯨꯡ ꯑꯦꯛꯁꯤꯂ ꯭ ꯔꯣꯗ ꯄ ꯭ ꯔꯥꯏꯚꯦꯠ ꯂꯤꯃꯤꯇꯦꯗꯀꯤ ꯈꯨꯠꯊꯥꯡꯗ 5.02% ꯑꯁꯤ ꯍꯛꯊꯦꯡꯅꯅ ꯂꯧꯁꯤꯟꯕ ꯌꯥꯎꯔꯤ ꯫
- ꯁꯦꯌꯔꯁꯤꯡ ꯑꯁꯤ ꯑꯦꯀ ꯭ ꯋꯤꯌꯔꯔ ꯇ ꯭ ꯔꯁ ꯭ ꯠꯇ ꯌꯦꯡꯁꯤꯟꯕ ꯑꯃꯠꯇ ꯌꯥꯎꯗꯅ ꯊꯥꯗꯣꯛꯄꯅꯤ ꯫
- ꯑꯦꯀ ꯭ ꯋꯤꯌꯔꯔ ꯇ ꯭ ꯔꯁ ꯭ ꯠ ꯑꯁꯤ ꯏꯟꯗꯤꯌꯟ ꯇ ꯭ ꯔꯁ ꯭ ꯠꯁ ꯑꯦꯛ ꯭ ꯠ 1882ꯒꯤ ꯃꯈꯥꯗ 2025ꯒꯤ ꯖꯨꯂꯥꯏ ꯇꯥꯡ 24ꯒꯤ ꯇ ꯭ ꯔꯁ ꯭ ꯠ ꯗꯤꯗ ꯑꯃ ꯑꯃꯁꯨꯡ 2026ꯀꯤ ꯃꯦ ꯇꯥꯡ 4ꯒꯤ ꯁꯦꯝꯗꯣꯛ-ꯁꯦꯝꯖꯤꯟ ꯑꯃꯒ ꯂꯣꯏꯅꯅ ꯂꯤꯡꯈꯠꯈꯤ ꯫
- ꯇ ꯭ ꯔꯥꯟꯖꯦꯛꯁꯟ ꯑꯁꯤ ꯄ ꯭ ꯔꯣꯃꯣꯇꯔ ꯏꯃꯨꯡꯒꯤ ꯃꯅꯨꯡꯗ ꯃꯊꯪ-ꯃꯅꯥꯎ ꯅꯥꯏꯅ ꯁꯦꯝꯗꯣꯛ-ꯁꯦꯝꯖꯤꯟ ꯇꯧꯕ ꯑꯣꯏꯅ ꯃꯁꯛ ꯇꯥꯛꯂꯤ ꯫
ꯑꯦ. ꯑꯥꯏ. ꯅ ꯗꯣꯀꯨꯃꯦꯟ ꯭ ꯇ ꯑꯗꯨꯗꯒꯤ ꯏꯈꯤ, ꯑꯃꯁꯨꯡ ꯃꯗꯨꯒꯤ ꯃꯥꯌꯣꯛꯇ ꯌꯦꯡꯁꯤꯟꯈꯤ ꯫ ꯃꯈꯥꯗ ꯄꯤꯔꯤꯕ ꯑꯁꯦꯡꯕ ꯑꯁꯤ ꯍꯛꯆꯤꯟꯕꯅꯤ ꯫
ꯑꯁꯦꯡꯕ ꯆꯦ ꯑꯗꯨ
ꯆꯦꯒꯤ ꯑꯀꯨꯞꯄ ꯃꯔꯣꯜꯁꯤꯡ
| ꯑꯣꯐꯤꯁ ꯭ ꯌꯦꯜ ꯇꯥꯏꯇꯦꯜ | ꯋꯥꯗꯤꯂꯥꯜ ꯑꯦꯟꯇꯔꯄ ꯭ ꯔꯥꯏꯖ ꯭ ꯁ ꯂꯤꯃꯤꯇꯦꯗꯀꯤ ꯃꯇꯥꯡꯗ ꯑꯦꯛ ꯭ ꯁꯞꯃꯦꯟꯁ ꯑꯣꯔꯗꯔ |
| ꯁꯣꯔꯁ ꯕꯣꯗꯤ | ꯁꯦꯀ ꯭ ꯌꯨꯔꯤꯇꯤꯁ ꯑꯦꯟꯗ ꯑꯦꯛꯆꯦꯟꯖ ꯕꯣꯔ ꯭ ꯗ ꯑꯣꯐ ꯏꯟꯗꯤꯌꯥ (ꯁꯦꯕꯤ)-ꯏꯟꯐꯣꯔꯁꯃꯦꯟ ꯭ ꯇ ꯑꯣꯔꯗꯔꯁꯤꯡ |
| ꯔꯤꯐꯔꯦꯟꯁ ꯅꯝꯕꯔ | WTM/KCV/CFD/04/2026-27 |
| ꯐꯤꯕꯝ | ꯑꯃꯠꯇ ꯂꯩꯇꯦ ꯫ (ꯑꯣꯔꯗꯔ) |
| ꯆꯍꯤ | 2026 |
| ꯂꯣꯏꯁꯤꯟꯕꯒꯤ ꯇꯥꯡ | — |
| ꯆꯦ-ꯆꯥꯡꯁꯤꯡ | 1 |